1887
Volume 2015, Issue 4
  • ISSN: 2305-7823
  • E-ISSN:

Abstract

Hypertension is a major risk factor for several cardiovascular diseases (CVD). The prevalence of hypertension is increasing in Bangladesh, especially in urban areas. The objective of this study was to estimate the prevalence of hypertension and its risk factors in an urban area of Bangladesh. We conducted a cross-sectional survey involving participants aged ≥ 25 years in an urban area in Dhaka between June-December 2012, using multi-stage random sampling. Data on socioeconomic status, tobacco use, physical activity, diet, extra-salt use, family history of hypertension, CVD, anthropometric measurements and blood pressure were collected using modified WHO-STEPS protocol. Hypertension and pre-hypertension were defined according to JNC-7. Multiple logistic regressions models were used to identify risk factors associated with hypertension. The overall age-adjusted prevalence hypertension and pre-hypertension among 730 participants was 23.7% and 19%, respectively, which was higher among males compared to females (23.6% vs 21.71% and 21.7% vs 17.0%, respectively). Bivariate analysis showed significant relationship of hypertension with age, BMI, no physical activity, tobacco use, extra salt intake and family history of stroke/cardiovascular disease. In the multivariate model, factors significantly associated with hypertension were older age (OR 19.18, 95% CI 13.58–28.11), smoking (OR 3.47, 95% CI 2.85–5.19), extra salt intake (OR 1.13, 95% CI 1.04–2.21), and high waist circumference (OR 3.41, 95% CI 2.81–5.29). The prevalence of hypertension and pre-hypertension was high among our study participants. Population-based intervention programs and policies for increased awareness about the risk factors, and life-style modification are essential for prevention of hypertension.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2015.43
2015-11-20
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2015/4/gcsp.2015.43.html?itemId=/content/journals/10.5339/gcsp.2015.43&mimeType=html&fmt=ahah

References

  1. Lim SS, Vos T, Flaxman AD, Danaei G, et al., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2013; 380:9859:22242260.
    [Google Scholar]
  2. Campbell NRC, Lackland DT, Niebylski ML, World Hypertension League Committee; International Society of Hypertension Executive Committee . High Blood Pressure: Why Prevention and Control Are Urgent and Important—A 2014 Fact Sheet From the World Hypertension League and the International Society of Hypertension. The Journal of Clinical Hypertension. 2014; 16:8:551553.
    [Google Scholar]
  3. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D&Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. Jama. 2002; 287:8:10031010.
    [Google Scholar]
  4. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Bmj. 2005; 330:7491:565.
    [Google Scholar]
  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee . Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42:6:12061252.
    [Google Scholar]
  6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The Lancet. 2005; 365:9455:217223.
    [Google Scholar]
  7. Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. Journal of hypertension. 2000; 18:5:521529.
    [Google Scholar]
  8. Lawes CM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. The Lancet. 2008; 371:9623:15131518.
    [Google Scholar]
  9. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. Journal of hypertension. 2009; 27:7:14721477.
    [Google Scholar]
  10. Karan A, Engelgau M, Mahal A. The household-level economic burden of heart disease in India. Tropical Medicine & International Health. 2014; 19:5:581591.
    [Google Scholar]
  11. Alwan A . Global status report on noncommunicable diseases 2010. 2011: World Health Organization.
  12. Mozaffarian D, Afshin A, Benowitz NL, Bittner V, Daniels SR, Franch HA, Jacobs DR Jr, Kraus WE, Kris-Etherton PM, Krummel DA, Popkin BM, Whitsel LP, Zakai NA, American Heart Association Council on Epidemiology and Prevention, Council on Nutrition, Physical Activity and Metabolism, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on the Kidney in Cardiovasc . Population Approaches to Improve Diet, Physical Activity, and Smoking Habits A Scientific Statement From the American Heart Association. Circulation. 2012; 126:12:15141563.
    [Google Scholar]
  13. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008; 52:5:818827.
    [Google Scholar]
  14. Organization WH, I.S.o.H.W. Group . 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of hypertension. 2003; 21:11:19831992.
    [Google Scholar]
  15. Perkovic V, Huxley R, Wu Y, Prabhakaran D, MacMahon S. The burden of blood pressure-related disease a neglected priority for global health. Hypertension. 2007; 50:6:991997.
    [Google Scholar]
  16. Ibrahim MM, Damasceno A. Hypertension in developing countries. The Lancet. 2012; 380:9841:611619.
    [Google Scholar]
  17. Das SK, Sanyal K, Basu A. Study of urban community survey in India: growing trend of high prevalence of hypertension in a developing country. International Journal of Medical Sciences. 2005; 2:2:7078.
    [Google Scholar]
  18. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. Jama. 2007; 297:3:286294.
    [Google Scholar]
  19. Moniruzzamani AT, Rahmani S, Acharyyai A, Islami FA, Mansur Ahmedi MSA, Mostafa Zamanii M. Prevalence of hypertension among the Bangladeshi adult population: a meta-analysis. in Regional Health Forum. 20131711519.
    [Google Scholar]
  20. Islam A, Majumder AA. Hypertension in Bangladesh: a review. Indian heart journal. 2012; 64:3:319323.
    [Google Scholar]
  21. Saquib N, Saquib J, Ahmed T, Khanam MA, Cullen MR. Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010. BMC public health. 1995; 12:1:434.
    [Google Scholar]
  22. Organization WH. WHO STEPS surveillance manual: the WHO STEPwise approach to chronic disease risk factor surveillance. 2005: WHO.
    [Google Scholar]
  23. Razzaque A, Nahar L, Golam Mustafa AHM, Ahsan KZ, Islam MS, Yunus M. Sociodemographic differentials of selected noncommunicable diseases risk factors among adults in Matlab, Bangladesh: findings from a WHO STEPS survey. Asia-Pacific Journal of Public Health. 2011; 23:2:183191.
    [Google Scholar]
  24. Lenfant C, Chobanian AV, Jones DW, Roccella EJ, Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure . Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) resetting the hypertension sails. Circulation. 2003; 107:24:29932994.
    [Google Scholar]
  25. Saquib N, Saquib N, Khanam MA, Saquib J, Anand S, Chertow , Barry M, Ahmed T, Cullen MR. High prevalence of type 2 diabetes among the urban middle class in Bangladesh. BMC public health. 2013; 13:1:1032.
    [Google Scholar]
  26. Alam DS, Haider Chowdhury MA, Siddiquee AT, Ahmed S, Niessen LW. Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort. BMJ open. 2014; 4:12:e004983.
    [Google Scholar]
  27. Chowdhury R, Alam DS, Fakir II. The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and design. European Journal of Epidemiology. July 2015; 30:7:577587.
    [Google Scholar]
  28. Gupta R. Trends in hypertension epidemiology in India. Journal of human hypertension. 2004; 18:2:7378.
    [Google Scholar]
  29. Bansal SK, Saxena V, Kandpal SD, Gray WK, Walker RW, Goel D. The prevalence of hypertension and hypertension risk factors in a rural Indian community: A prospective door-to-door study. Journal of cardiovascular disease research. 2012; 3:2:117123.
    [Google Scholar]
  30. Devi P, Rao M, Sigamani A, Faruqui A, Jose M, Gupta R, Kerkar P, Jain RK, Joshi R, Chidambaram N, Rao DS, Thanikachalam S, Iyengar SS, Verghese K, Mohan V, Pais P, Xavier D. Prevalence, risk factors and awareness of hypertension in India: a systematic review. Journal of human hypertension. 2012; 27:5:281287.
    [Google Scholar]
  31. Padmavati S. Prevention of heart disease in India in the 21 st century: Need for a concerted effort. Indian heart journal. 2002; 54:1:99102.
    [Google Scholar]
  32. Islam SMS, Alam DS, Wahiduzzaman M, Niessen LW, Froeschl G, Ferrari U, Seissler J, Rouf HMA, Lechner A. Clinical characteristics and complications of patients with type 2 diabetes attending an urban hospital in Bangladesh. Diabetes & Metabolic Syndrome: Clinical Research & Reviews , 201491713.
  33. Rahim M, Hussain A, Azad Khan AK, Sayeed MA, Keramat Ali SM, Vaaler S. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes research and clinical practice. 2007; 77:2:300305.
    [Google Scholar]
  34. Rahman MA, Zaman MM. Smoking and smokeless tobacco consumption: Possible risk factors for coronary heart disease among young patients attending a tertiary care cardiac hospital in Bangladesh. Public Health. 122:12:13311338.
    [Google Scholar]
  35. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S, INTERHEART Study Investigators . Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. The Lancet. 2006; 368:9536:647658.
    [Google Scholar]
  36. Mozaffarian D, Fahimi S, Singh GM. Global Sodium Consumption and Death from Cardiovascular Causes. New England Journal of Medicine. 2014; 371:7:624634.
    [Google Scholar]
  37. de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Yaqoob MM, Dobbie H. Barriers and facilitators of dietary sodium restriction amongst Bangladeshi chronic kidney disease patients. Journal of Human Nutrition and Dietetics. 2011; 24:1:8695.
    [Google Scholar]
  38. Lock K, Pomerleau J, Causer L, Altmann DR, McKee M. The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bulletin of the World Health Organization. 2005; 83:2:100108.
    [Google Scholar]
  39. Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. 2011: World Health Organization.
    [Google Scholar]
  40. Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. The American journal of clinical nutrition. 2002; 76:1:9399.
    [Google Scholar]
  41. Wang X, Wang X, Yingying , Liu J, Zhu M, Zhao G, Bao W, Hu FB. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. bmj. 2014; 349::g4490.
    [Google Scholar]
  42. Alamgir A, Akhter S. Hypertension Prevalence and Related Factors in an Urban Affluent Community in Bangladesh. Bang J Med Sci. 2005; 11:1:2225.
    [Google Scholar]
  43. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. The Lancet. 2001; 358:9294:16821686.
    [Google Scholar]
  44. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee . The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003; 289:19:25602571.
    [Google Scholar]
  45. Choudhury KN, Mainuddin AK, Wahiduzzaman M, Islam SM. Serum lipid profile and its association with hypertension in Bangladesh. Vascular health and risk management. 2014; 10::327.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2015.43
Loading
/content/journals/10.5339/gcsp.2015.43
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): Bangladesh , cardiovascular diseases , prevalence and risk factors, hypertension
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error